Pituitary-adrenal function in ten patients receiving medroxyprogesterone acetate for true precocious puberty.
D015065:17-Hydroxycorticosteroids / Q000097:blood; D000324:Adrenocorticotropic Hormone / Q000096:biosynthesis; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003864:Depression, Chemical; D005260:Female; D005938:Glucocorticoids / Q000652:urine; D006801:Humans; D008297:Male; D008525:Medroxyprogesterone / Q000627:therapeutic use*; D008797:Metyrapone; D010902:Pituitary Gland / Q000378:metabolism; D010912:Pituitary-Adrenal Function Tests; D010913:Pituitary-Adrenal System / Q000187:drug effects*; D011629:Puberty, Precocious / Q000188:drug therapy* / Q000503:physiopathology*
D015065:17-Hydroxycorticosteroids; D005938:Glucocorticoids; D000324:Adrenocorticotropic Hormone; D008525:Medroxyprogesterone; D008797:Metyrapone